Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis
- PMID: 12649712
- DOI: 10.1007/s10096-003-0902-x
Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis
Abstract
The aim of this study was to analyze medical outcomes, including risks for complications and mortality, in 332 adult patients hospitalized for cellulitis. The infection was documented microbiologically in 128 cases (39%). Staphylococcus aureus (46 cases) and Streptococcus pyogenes (22 cases) were the most frequent causative pathogens. Overall, 63 patients (19%) were discharged early (< or =4 days) and 166 patients (50%) were hospitalized for more than 4 days without developing any complications. One hundred three patients (31%) had one or more complications or died. Of these, 78 required surgical debridement, 10 required plastic surgery, 7 underwent amputation, and 15 had shock on presentation. When comparing the three study groups (patients discharged early, patients hospitalized for < or =4 days without complications, and patients who developed 1 or more complication or who died), patients who were discharged early (low risk) were more frequently female and were less likely to have multiple comorbid conditions, hypoalbuminemia, renal insufficiency, and/or cutaneous necrosis at presentation. Overall mortality (<30 days) was 5% (16/332 patients). Factors associated with death were male sex, presence of multiple comorbid conditions, congestive heart failure, morbid obesity, hypoalbuminemia, renal insufficiency, shock, and Pseudomonas aeruginosa cellulitis. These findings can be used to stratify patients with acute cellulitis according to risks for complications and mortality and may be helpful when deciding the most appropriate means of care, i.e. outpatient treatment or hospitalization.
Similar articles
-
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?Clin Mol Hepatol. 2019 Aug;25(3):317-325. doi: 10.3350/cmh.2018.0097. Epub 2019 Jun 10. Clin Mol Hepatol. 2019. PMID: 31177653 Free PMC article.
-
Evaluation of microbiological spectrum and risk factors of cellulitis in hospitalized patients.Cutan Ocul Toxicol. 2011 Sep;30(3):221-4. doi: 10.3109/15569527.2011.554482. Epub 2011 Feb 24. Cutan Ocul Toxicol. 2011. PMID: 21345156
-
Bacteremic pneumococcal cellulitis compared with bacteremic cellulitis caused by Staphylococcus aureus and Streptococcus pyogenes.Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):337-41. doi: 10.1007/s10096-003-0945-z. Epub 2003 Jun 3. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12783279
-
[Management of cervical cellulitis with and without mediastinal extension: report of 17 cases].Rev Laryngol Otol Rhinol (Bord). 2010;131(3):187-92. Rev Laryngol Otol Rhinol (Bord). 2010. PMID: 21491772 Review. French.
-
Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.J Gen Intern Med. 2018 Sep;33(9):1553-1560. doi: 10.1007/s11606-018-4546-z. Epub 2018 Jul 18. J Gen Intern Med. 2018. PMID: 30022408 Free PMC article.
Cited by
-
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin.J Antimicrob Chemother. 2016 Mar;71(3):821-9. doi: 10.1093/jac/dkv411. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679243 Free PMC article. Clinical Trial.
-
Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study.Antibiotics (Basel). 2025 Jan 12;14(1):75. doi: 10.3390/antibiotics14010075. Antibiotics (Basel). 2025. PMID: 39858361 Free PMC article.
-
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.Vaccine. 2012 Dec 14;30(52):7594-600. doi: 10.1016/j.vaccine.2012.10.038. Epub 2012 Oct 22. Vaccine. 2012. PMID: 23099329 Free PMC article. Clinical Trial.
-
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.N Engl J Med. 2015 Mar 19;372(12):1093-103. doi: 10.1056/NEJMoa1403789. N Engl J Med. 2015. PMID: 25785967 Free PMC article. Clinical Trial.
-
Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis.Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2147-52. doi: 10.1007/s10096-012-1549-2. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22298240
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical